AMVISC: payments to doctors
Payments that named AMVISC as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $40K
- Providers
- 240
- Transactions
- 430
- Average per transaction
- $93
The per-transaction average — $93 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 240 providers the average total is $167, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bausch & Lomb Americas Inc. | $38,281 | 95.2% |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $1,850 | 4.6% |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $40 | 0.1% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $22 | 0.1% |